Thumbnail
Access Restriction
Open

Author Finn, R. D. ♦ Macapinlac, H. ♦ Humm, J. ♦ Pentlow, K. ♦ McDevitt, M. ♦ Tjuvajev, J. ♦ Blasberg, R. ♦ Scheinberg, D. ♦ Larson, S. ♦ Zweit, J.
Sponsorship USDOE
Source United States Department of Energy Office of Scientific and Technical Information
Content type Text
Language English
Subject Keyword BIOLOGY AND MEDICINE, BASIC STUDIES ♦ NUCLEAR MEDICINE ♦ POSITRON COMPUTED TOMOGRAPHY ♦ LABELLED COMPOUNDS ♦ RADIOISOTOPES ♦ NEOPLASMS ♦ ACCELERATORS ♦ ISOTOPE PRODUCTION
Abstract Nuclear medicine is the specialty of medical imaging which utilizes a variety of radionuclides incorporated into specific compounds for diagnostic imaging and therapeutic applications. During recent years, research efforts in this discipline have concentrated on the decay characteristics of particular radionuclides and the design of unique radio-labeled tracers necessary to achieve the time-dependent molecular image. Preliminary results from our laboratory directed at oncologic applications include the preparation of specific PET radionuclides which allow an extension from functional process imaging in tissue to pathologic processes and nuclide directed treatments. Illustrative examples and operational considerations of specific accelerator-produced radionuclides are presented. {copyright} {ital 1997 American Institute of Physics.}
ISSN 0094243X
Educational Use Research
Learning Resource Type Article
Publisher Date 1997-02-01
Publisher Place United States
Volume Number 392
Issue Number 1
Technical Publication No. CONF-961110-


Open content in new tab

   Open content in new tab